A significant collaboration has been established between NJ Bio, Inc. ("NJ Bio") in Princeton, N.J., and Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma") in Tokyo, as of April 1, 2026. Both companies are key players in their respective fields - NJ Bio specializing in integrated drug discovery and development services, while Aji Bio-Pharma excels in biopharmaceutical manufacturing services and platform expertise. This partnership marks a pivotal moment in the industry, bringing together top talents and resources from two leading entities in the biopharmaceutical sector. Stay tuned for further developments stemming from this collaboration.